Journey Medical (DERM) Cash from Operations (2020 - 2026)
Journey Medical (DERM) posted Cash from Operations of 2909000.0 for Q1 2026, up 146.29% on a QoQ basis from 6284000.0 in Q4 2025, and up 202.72% year-over-year from 960957.42 in Q1 2025.
Journey Medical (DERM) Cash from Operations (2020 - 2026) Analysis & Trends
Journey Medical's Cash from Operations history runs 7 years deep, the most recent figure standing at 2909000.0 for Q1 2026.
- Quarterly Cash from Operations rose 202.72% year-over-year to 2909000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6700000.0 (up 3.46% YoY) and the FY2025 annual result came in at 12441000.0, down 36.31% from the prior year.
- Cash from Operations was 2909000.0 for Q1 2026 at Journey Medical, up from 6284000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 18747000.0 in Q3 2023 and bottomed at 16520000.0 in Q4 2023.
- A 5-year average of 1585470.59 and a median of 2383000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 357.44% — and 2024, when it slumped 425.0%.
- Journey Medical's Cash from Operations stood at 3836000.0 in 2022, then plunged by 330.66% to 16520000.0 in 2023, then surged by 113.47% to 2225000.0 in 2024, then plunged by 382.43% to 6284000.0 in 2025, then jumped by 146.29% to 2909000.0 in 2026.
- Business Quant data shows DERM's Cash from Operations at 2909000.0 in Q1 2026, 6284000.0 in Q4 2025, and 2383000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | 2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -942,000.00 |
| Jun 30, 2025 | -942,000.00 |
| Mar 31, 2025 | -2.83 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Dec 31, 2023 | -16.52 Mn |
| Dec 31, 2023 | -16.52 Mn |